Please assess the completion status of the following clinical trial:

Trial Title: Immediate Postplacental IUD Insertion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female~* 18 yo or older~* Singleton pregnancy at ≥32 weeks gestation at time of enrollment~* Voluntarily requesting either copper T380A or levonorgestrel IUD (LNG-IUS) placement for postpartum contraception~* English or Spanish speaking~* Able to give consent and agree to the terms of the study~* Less than 10 prenatal visits or 2 or more no show visits~* Since IUDs are not on our hospital formulary, the patient must qualify for a Long Acting Reversible Contraceptive (LARC) IUD (this includes all Oregon Health Plan (OHP) or Citizen/Alien Waived Emergent Medical (CAWEM) insured patients or women with income \<300% of the federal poverty line).~Exclusion Criteria:~* Anatomic uterine abnormalities that prevent proper fundal placement of IUD (obstructive myomata, bicornuate, septate, etc)~* Chorioamnionitis (also consider other risk factors such as prolonged rupture of membranes \>18 hours, prolonged labor \>24 hours, fever \>38C)~* Puerperal sepsis~* Unresolved postpartum hemorrhage~* Extensive genital trauma~* Current incarceration~* Known or suspected untreated endocervical gonorrhea, chlamydia~* Wilson's disease, copper allergy (Paragard only)~* Known or suspected cervical or endometrial cancer or pelvic tuberculosis~* Current breast cancer (LNG-IUS only)~* Systemic lupus erythematosus (SLE) with severe thrombocytopenia (Paragard only)~* Trophoblastic disease (benign or malignant)~* AIDS not stable on antiretroviral

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Immediate postplacental IUD insertion (Type: EXPERIMENTAL): Women randomized to the immediate postplacental IUD group will receive their IUD within 60 minutes of placental delivery.
- 6 weeks postpartum IUD insertion (Type: ACTIVE_COMPARATOR): Subjects who are randomized for IUD insertion at their postpartum visit will be assisted in scheduling a postpartum visit and IUD placement with their usual obstetrical care provider.

Based on this trial design, predict the completion outcome and termination type (if applicable).